000 01375 a2200397 4500
005 20250517014411.0
264 0 _c20150413
008 201504s 0 0 eng d
022 _a1538-7445
024 7 _a10.1158/0008-5472.CAN-13-3043
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFinegan, Katherine G
245 0 0 _aERK5 is a critical mediator of inflammation-driven cancer.
_h[electronic resource]
260 _bCancer research
_cFeb 2015
300 _a742-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarcinogenesis
_xgenetics
650 0 4 _aCarcinogens
_xtoxicity
650 0 4 _aEpidermis
_xmetabolism
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aInflammation
_xchemically induced
650 0 4 _aKeratinocytes
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aMitogen-Activated Protein Kinase 7
_xbiosynthesis
650 0 4 _aSkin Neoplasms
_xchemically induced
700 1 _aPerez-Madrigal, Diana
700 1 _aHitchin, James R
700 1 _aDavies, Clare C
700 1 _aJordan, Allan M
700 1 _aTournier, Cathy
773 0 _tCancer research
_gvol. 75
_gno. 4
_gp. 742-53
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-13-3043
_zAvailable from publisher's website
999 _c24592709
_d24592709